Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

The conversation discusses the molecular structures of compounds that reduce DHT levels, including finasteride and Ashwagandha. It explores the potential of using Ashwagandha topically as a 5a reductase inhibitor.

An 18-year-old using finasteride and minoxidil is concerned about whether finasteride affects facial structure development. A response suggests low DHT levels likely don't impact face structure unless testosterone levels are affected.

The user is using a topical spray containing finasteride, minoxidil, ketoconazole, and biotin for hair loss and plans to add weekly dermastamping, starting with a needle length of 0.6mm. They seek advice on the safety of combining these treatments, the impact of skipping one dose weekly, and the frequency of replacing the dermastamp.

A 24-year-old shared his hair loss journey, using finasteride and topical minoxidil for 6 months with positive results and no side effects. He recommends growing hair out and getting a good haircut to improve appearance and confidence.

The conversation discusses the lack of public information on the chemical structure of PP405, a hair loss treatment, and the challenges of synthesizing it without a patent. It also explores a patent related to hydrogen-based topical formulations for reducing oxidative stress and inflammation.